Published Date: 05/24/2022
Expiration Date: 12/14/2024
This course will discuss the importance of treating HCV among people who inject drugs (PWID). It will highlight and describe why PWID are a priority population for enhancing HCV prevention, screening and linkage to care and treatment. It will review the epidemiology of HCV among PWID, HCV transmission and the role of injection drug use in transmission, the efficacy of current direct acting antivirals for this population and discuss innovative strategies and models of HCV care for PWID.
Effective June 27, 2023 the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a one-time requirement of 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for practitioners who are applying for or renewing their DEA license. This 1-hour ACCME-accredited course meets the DEA/SAMHSA requirement.